Notes - Segment Information

Sumitomo Pharma Co., Ltd. - Filing #7249083

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
Notes - Segment information
Segment information
Revenue
Revenue from external customers
99,838,000,000 JPY
47,180,000,000 JPY
398,832,000,000 JPY
251,814,000,000 JPY
159,037,000,000 JPY
314,558,000,000 JPY
114,657,000,000 JPY
40,864,000,000 JPY
Revenue
398,832,000,000 JPY
314,558,000,000 JPY
Share of profit (loss) of investments accounted for using equity method
-905,000,000 JPY
-23,000,000 JPY
Profit (loss) before tax
17,611,000,000 JPY
-323,114,000,000 JPY
Assets
742,604,000,000 JPY
907,506,000,000 JPY
Investments accounted for using equity method
5,588,000,000 JPY
360,000,000 JPY
Depreciation and amortization
6,097,000,000 JPY
1,213,000,000 JPY
22,613,000,000 JPY
15,303,000,000 JPY
27,178,000,000 JPY
34,436,000,000 JPY
6,055,000,000 JPY
1,203,000,000 JPY
Impairment losses
5,463,000,000 JPY
JPY
5,189,000,000 JPY
-274,000,000 JPY
177,070,000,000 JPY
180,857,000,000 JPY
3,787,000,000 JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.